Dr. Hamedifar initiated and led the project to develop the first full-cycle biosimilar candidate in the region back in 2002, a co-development project between Fraunhofer Institute and CinnaGen, the successful outcome of this project paved the way to establish the advanced biopharmaceutical infrastructure in the region. Since then, CinnaGen has become a major player in biopharmaceutical era, focusing on large scale manufacturing of biosimilars with world-class quality. CinnaGen provides life-saving treatments through a diverse range of products for conditions such as multiple sclerosis (MS), cancer, respiratory illnesses, and various rare diseases.
General Inquiries
Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.